Jung, Su Young <br/><br/>
Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study.  [electronic resource] 

 -  Investigational new drugs  06 2020 
 - 812-820 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-019-00835-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aniline Compounds--pharmacokinetics<br/>Area Under Curve<br/>Drug Administration Schedule<br/>Female<br/>Half-Life<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Receptor, Transforming Growth Factor-beta Type I--antagonists & inhibitors<br/>Triazoles--pharmacokinetics